Brief: Enveric Biosciences Files Provisional Patent Application For AI-Based Computational Methods For Identifying And Optimizing Novel Tryptamine Derivatives
11/09/2023 13:44
Sept 11 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES FILES PROVISIONAL PATENT APPLICATION
FOR
AI-BASED COMPUTATIONAL METHODS FOR IDENTIFYING AND OPTIMIZING
NOVEL TRYPTAMINE DERIVATIVES
Source text for Eikon: ID:nBw3YCd1ka
Further company coverage: ENVB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003